Democrat · New York's 3rd District · 2026
Tom Suozzi
Suozzi grew up in Glen Cove with an Italian immigrant father and a mother from Queens.
Biography
As a Fordham law student, Tom Suozzi recruited classmates from the library to help make sandwiches at a nearby soup kitchen.1 His father was an Italian immigrant who became a judge; his mother was a nurse and community activist.1 He lives in Glen Cove with his wife, Helene, and they have three children.2
Suozzi earned his bachelor's degree at Boston College and his law degree at Fordham.3 His work outside elected office has included auditing at Arthur Andersen, clerking for a federal judge, litigation at Shearman & Sterling and advising at Lazard.2 He also helped build Fordham's student Public Service Project, connecting classmates with volunteer opportunities.1
He served as Glen Cove mayor from 1994 through 2001 and Nassau County executive from 2002 through 2009.3 His first stretch in Congress ran from 2017 to January 2023; he returned through the February 2024 special election.3 He serves on Ways and Means and the committee focused on competition with China, and cochairs the bipartisan Problem Solvers Caucus.2
Suozzi is seeking reelection as the 3rd District's Democrat.4 His priorities include restoring the full state and local tax deduction, protecting Medicare and Medicaid, reducing prescription drug costs and preserving medical research.5 He calls for immigration changes that combine border security with humane treatment of migrants.5
Record and controversies
Historical stock disclosure review
In February 2022, the Office of Congressional Ethics referred allegations about Suozzi's stock transaction reports to the House Ethics Committee, recommending further review because it believed he had failed to file required reports.6 On July 29, 2022, the committee unanimously dismissed the referral.6 It found no clear evidence that the errors and omissions were knowing or willful, said the members involved had been unclear about reporting requirements and noted their efforts to correct the records and comply in the future.6
Biotechnology investment and disclosure values
A November 2024 New York Focus investigation reported that Suozzi had listed his stake in Clarapath on financial disclosures but sometimes reported its value as unknown or none, despite investing additional money.7 It examined Northwell Health's investment in the company alongside Suozzi's federal funding work for Northwell and Cold Spring Harbor Laboratory, expressly noting no evidence that those earmarks supported Clarapath.7 His office maintained that he complied with the rules and sought House Ethics guidance about valuing the private investment.7 His September 2024 amended disclosure listed the stake in the $250,001 to $500,000 range, with a note that its actual value was undetermined.8